These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 14685055)

  • 1. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
    Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
    AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
    Saraceni V; Durovni B; Cavalcante SC; Cohn S; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    Braz J Infect Dis; 2014; 18(5):491-5. PubMed ID: 24780362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
    Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.
    Soeters HM; Sawry S; Moultrie H; Rie AV
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):136-44. PubMed ID: 25072611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
    Schmaltz CA; Santoro-Lopes G; Lourenço MC; Morgado MG; Velasque Lde S; Rolla VC
    PLoS One; 2012; 7(9):e45704. PubMed ID: 23049842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
    Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
    PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.
    Périssé AR; Smeaton L; Chen Y; La Rosa A; Walawander A; Nair A; Grinsztejn B; Santos B; Kanyama C; Hakim J; Nyirenda M; Kumarasamy N; Lalloo UG; Flanigan T; Campbell TB; Hughes MD;
    PLoS One; 2013; 8(12):e83643. PubMed ID: 24391801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART.
    Zanoni BC; Phungula T; Zanoni HM; France H; Feeney ME
    AIDS; 2011 Jan; 25(1):49-55. PubMed ID: 20935555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?
    Breen RA; Smith CJ; Cropley I; Johnson MA; Lipman MC
    AIDS; 2005 Jul; 19(11):1201-6. PubMed ID: 15990574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil.
    Schmaltz CA; Sant'Anna FM; Neves SC; Velasque Lde S; Lourenço MC; Morgado MG; Rolla VC; Lopes GS
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):623-8. PubMed ID: 19730270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous HAART improves survival in children coinfected with HIV and TB.
    Pensi T; Hemal A; Banerjee T
    Trop Med Int Health; 2012 Jan; 17(1):52-8. PubMed ID: 21967134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
    Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
    PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
    Kwara A; Carter EJ; Rich JD; Flanigan TP
    AIDS Patient Care STDS; 2004 Jun; 18(6):341-7. PubMed ID: 15294084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.
    Velasco M; Castilla V; Sanz J; Gaspar G; Condes E; Barros C; Cervero M; Torres R; Guijarro C;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):148-52. PubMed ID: 19131895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
    Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
    Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.
    Girardi E; Palmieri F; Cingolani A; Ammassari A; Petrosillo N; Gillini L; Zinzi D; De Luca A; Antinori A; Ippolito G
    J Acquir Immune Defic Syndr; 2001 Apr; 26(4):326-31. PubMed ID: 11317073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.